What is Afatinib Dimaleate 30 mg?
Afatinib Dimaleate 30 mg is a prescription medication primarily used to treat non-small cell lung cancer (NSCLC). Manufactured by Boehringer Ingelheim India Pvt.Ltd, this drug serves as a targeted therapy for patients diagnosed with specific types of lung cancer, helping to manage disease progression and improve quality of life.
This medication is specifically designed for patients with NSCLC whose tumors have mutations in the epidermal growth factor receptor (EGFR) gene. Its availability in Canada provides a vital treatment option for individuals seeking effective cancer care within a well-regulated pharmaceutical market.
Uses of Afatinib Dimaleate 30 mg
- Treatment of locally advanced or metastatic non-small cell lung cancer
- For patients with EGFR mutation-positive NSCLC
- Used as first-line therapy for NSCLC in eligible patients
- Management option for patients intolerant or resistant to other EGFR inhibitors
How Afatinib Dimaleate 30 mg Works
Afatinib Dimaleate is a tyrosine kinase inhibitor that irreversibly binds to and blocks the activity of EGFR, along with other members of the HER receptor family. This action prevents the signaling pathways that promote cancer cell growth and survival. By inhibiting these pathways, the drug helps to slow down or stop the proliferation of cancer cells in the lungs.
The targeted mechanism allows Afatinib Dimaleate 30 mg to specifically act on cancer cells with EGFR mutations, sparing many healthy cells and potentially reducing the severity of side effects compared to traditional chemotherapy.
Benefits of Afatinib Dimaleate 30 mg
- Specifically targets EGFR mutation-positive lung cancer cells
- Oral administration for convenient dosing
- Helps control tumor growth and disease progression
- Improves progression-free survival in NSCLC patients
- Manufactured by a reputable pharmaceutical company ensuring quality and safety
Dosage and Administration
Afatinib Dimaleate 30 mg is typically taken once daily, preferably at the same time each day. It is important to follow the dosage prescribed by your healthcare provider, as dosage adjustments may be necessary based on patient response and tolerance.
The medication can be taken with or without food but should be swallowed whole with water. Patients should avoid missing doses and consult their doctor immediately if a dose is missed.
Who Should Use Afatinib Dimaleate 30 mg?
This medication is suitable for adult patients diagnosed with non-small cell lung cancer that test positive for EGFR mutations. It is an option for those requiring targeted treatment to manage their condition effectively. Prior consultation with an oncologist and thorough genetic testing are essential before starting therapy.
Who Should Avoid Afatinib Dimaleate 30 mg?
Afatinib Dimaleate 30 mg should be avoided by individuals who have known hypersensitivity to afatinib or any components of the formulation. It is not recommended for use in patients with severe liver impairment or certain pre-existing medical conditions without close medical supervision. Pregnant or breastfeeding women should not use this medication unless advised by their healthcare provider.
Side Effects
- Diarrhea
- Skin rash
- Mouth sores
- Nausea
- Fatigue
- Decreased appetite
- Dry skin
- Itching
- Stomatitis
- Paronychia (nail infection/inflammation)
- Eye inflammation
Safety Advice
- Inform your doctor of any other medical conditions before starting treatment.
- Avoid exposure to sunlight or UV rays as skin sensitivity may increase.
- Stay hydrated especially if diarrhea occurs and seek medical advice promptly.
- Do not stop taking the medication without consulting your physician.
- Regular monitoring of liver function and other blood tests may be necessary.
- Report any severe or persistent side effects immediately to your healthcare provider.
Drug Interactions
- Strong CYP3A4 inducers may reduce effectiveness of the medication.
- CYP3A4 inhibitors can increase afatinib blood levels and risk of toxicity.
- Combining with other cancer therapies should be under strict medical supervision.
- Concurrent use with anticoagulants requires caution due to bleeding risk.
Storage Instructions
Store Afatinib Dimaleate 30 mg tablets at room temperature, away from moisture and heat. Keep the medication in its original packaging and out of reach of children. Do not use after the expiration date indicated on the packaging.
Where to buy Afatinib Dimaleate 30 mg in Canada?
Afatinib Dimaleate 30 mg is available for purchase at licensed pharmacies across Canada. Patients should only buy from reputable Canadian pharmacies with valid prescriptions. Online pharmacies serving the Canadian market may also provide the medication with proper prescription verification, ensuring access to genuine and safe products.
Frequently Asked Questions (FAQ)
Is Afatinib Dimaleate 30 mg available in Canada?
Yes, Afatinib Dimaleate 30 mg is available in Canada through licensed pharmacies and healthcare providers specializing in oncology medications.
What is the price of Afatinib Dimaleate 30 mg in Canada?
Prices can vary depending on the pharmacy, insurance coverage, and prescription plans. It is recommended to check with local pharmacies or health insurance providers for current pricing and coverage details.
What happens if I miss a dose?
If you miss a dose of Afatinib Dimaleate 30 mg, take it as soon as you remember unless it is almost time for your next dose. Do not double the dose to make up for a missed one. Consult your healthcare provider if unsure.
Where can I find Afatinib Dimaleate 30 mg for sale?
You can find Afatinib Dimaleate 30 mg at licensed pharmacies in Canada and authorized online pharmacies that require a valid prescription from your healthcare provider.
Can I take Afatinib Dimaleate 30 mg with other medications?
Some medications may interact with Afatinib Dimaleate. Always inform your doctor about all medications and supplements you are taking before starting therapy.
Is special monitoring necessary while using Afatinib Dimaleate 30 mg?
Yes, regular medical check-ups and laboratory tests are important to monitor your response and detect any side effects early.
Can pregnant or breastfeeding women use Afatinib Dimaleate 30 mg?
Use of this medication during pregnancy or breastfeeding is not recommended unless specifically advised by a healthcare professional due to potential risks.
Conclusion
Afatinib Dimaleate 30 mg represents a significant advancement in the targeted treatment of non-small cell lung cancer, particularly for patients with EGFR mutations. Manufactured by a trusted pharmaceutical company, it offers a convenient oral therapy option aimed at improving patient outcomes. Proper usage under medical supervision, awareness of possible side effects, and adherence to prescribed dosages are critical to maximizing benefits and safety. Patients in Canada seeking effective NSCLC treatment may consider discussing Afatinib Dimaleate 30 mg with their oncologist as part of a comprehensive cancer management plan.
Leave A Review